Abstract
Objective: Discussion and endorsement of the OMERACT total joint replacement (TJR) core domain set for total hip replacement (THR) and total knee replacement (TKR) for endstage arthritis; and next steps for selection of instruments. Methods: The OMERACT TJR working group met at the 2016 meeting at Whistler, British Columbia, Canada. We summarized the previous systematic reviews, the preliminary OMERACT TJR core domain set and results from previous surveys. We discussed preliminary core domains for TJR clinical trials, made modifications, and identified challenges with domain measurement. Results: Working group participants (n = 26) reviewed, clarified, and endorsed each of the inner and middle circle domains and added a range of motion domain to the research agenda. TJR were limited to THR and TKR but included all endstage hip and knee arthritis refractory to medical treatment. Participants overwhelmingly endorsed identification and evaluation of top instruments mapping to the core domains (100%) and use of subscales of validated multidimensional instruments to measure core domains for the TJR clinical trial core measurement set (92%). Conclusion: An OMERACT core domain set for hip/knee TJR trials has been defined and we are selecting instruments to develop the TJR clinical trial core measurement set to serve as a common foundation for harmonizing measures in TJR clinical trials.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1723-1726 |
| Number of pages | 4 |
| Journal | Journal of Rheumatology |
| Volume | 44 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 1 2017 |
| Externally published | Yes |
Bibliographical note
Funding Information:From the University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center, Birmingham, Alabama; Department of Orthopedics, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; University of Melbourne Department of Surgery, St. Vincent’s Hospital, Melbourne, Australia; Department of Orthopedic Surgery and Department of Medicine, University of Arizona, Tucson, Arizona; Weill Cornell Medical School and Hospital for Special Surgery, New York, New York; Healthy Motivation, and Global Alliance for Musculoskeletal Health, the Bone and Joint Decade, Santa Barbara, California, USA; Department of Psychology, Health and Technology, University of Twente, Enschede, the Netherlands. As part of the supplement series OMERACT 13, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. J.A. Singh, MBBS, MPH, Professor of Medicine and Epidemiology, University of Alabama at Birmingham and Staff Physician, Birmingham Veterans Affairs Medical Center, and Research Collaborator, Department of Orthopedics, Mayo Clinic College of Medicine; M.M. Dowsey, PhD, National Health and Medical Research Council Clinical Research Fellow, University of Melbourne Department of Surgery, St. Vincent’s Hospital; M. Dohm, MD, Assistant Professor, Department of Orthopedic Surgery and Department of Medicine, University of Arizona; S.M. Goodman, MD, Associate Professor of Clinical Medicine, Weill Cornell Medical School and Associate Attending Hospital for Special Surgery; A.L. Leong, MBA, President and CEO, Healthy Motivation, and Director of Strategic Relations, Global Alliance for Musculoskeletal Health, the Bone and Joint Decade; M.M. Scholte Voshaar, PhD, Research Fellow, Department of Psychology, Health and Technology, University of Twente; P.F. Choong, MBBS, MD, FRACS, FAOrthA Professor of Surgery, University of Melbourne, and Head of Department of Surgery, and Director of Orthopedic Surgery, St. Vincent’s Hospital. Address correspondence to J.A. Singh, MBBS, MPH, University of Alabama, Faculty Office Tower 805B, 510 20th St. S., Birmingham, Alabama 35294, USA. E-mail: [email protected]
Publisher Copyright:
Copyright © 2017. All rights reserved.
Keywords
- Arthroplasty
- Filter
- Omeract
- Outcome measures core set
- Total joint replacement